Monthly information on share capital and company voting rights
07 Settembre 2020 - 10:30PM
Monthly information on share capital and company voting rights
Listing market: Euronext Growth
ISIN code: FR0010425595
|
Date |
Total number of sharesin the
capital |
Total number of
voting rights |
|
08/31/2020 |
42,486,133 |
47,940,778 |
About CellectisCellectis is
developing the first of its kind allogeneic approach for CAR-T
immunotherapies in oncology, pioneering the concept of
off-the-shelf and ready-to-use gene-edited CAR T-cells to treat
cancer patients. As a clinical-stage biopharmaceutical company with
over 20 years of expertise in gene editing, Cellectis is developing
life-changing product candidates utilizing TALEN®, its gene editing
technology, and PulseAgile, its pioneering electroporation system
to harness the power of the immune system in order to target and
eradicate cancer cells.
As part of its commitment to a cure, Cellectis
remains dedicated to its goal of providing life-saving UCART
product candidates to address unmet needs for multiple cancers
including acute myeloid leukemia (AML), B-cell acute lymphoblastic
leukemia (B-ALL) and multiple myeloma (MM).
Cellectis headquarters are in Paris, France,
with additional locations in New York and Raleigh, North Carolina.
Cellectis is listed on the Nasdaq Global Market (ticker: CLLS) and
on Euronext Growth (ticker: ALCLS). For more information, visit
www.cellectis.com.
Follow Cellectis on social media: @cellectis,
LinkedIn and YouTube.
TALEN® is a registered trademark owned by
Cellectis.
For further information, please
contact:
Media contacts:Jennifer Moore, VP,
Communications, 917-580-1088, media@cellectis.comCaitlin Kasunich,
KCSA Strategic Communications, 212-896-1241, ckasunich@kcsa.com
IR contact:Simon Harnest, VP, Corporate
Strategy and Finance, 646-385-9008,
simon.harnest@cellectis.com PDF available
at: http://ml.globenewswire.com/Resource/Download/cb80f5e7-e4fa-458c-862b-575f7ec63538
Grafico Azioni Cellectis Nom Eo 05 (EU:ALCLS)
Storico
Da Mar 2024 a Apr 2024
Grafico Azioni Cellectis Nom Eo 05 (EU:ALCLS)
Storico
Da Apr 2023 a Apr 2024
